Background: To decipher the role of monocyte-derived macrophages (Mφs) in vascular remodeling of the occluded vein following experimental branch retinal vein occlusion (BRVO). Methods: The inflammation induced by laser-induced BRVO on mice retina was evaluated at different time points by RT-PCR looking at inflammatory markers mRNA level expression, Icam-1, Cd11b, F4/80, Ccl2, and Ccr2 and by quantification of Iba1-positive macrophage (Mφ) density on Iba1-stained retinal flatmount. Repeated intraperitoneal EdU injection combined with liposome clodronate-induced monocyte (Mo) depletion in wildtype mice was used to differentiate Mo-derived Mφs from resident Mφs. Liposome clodronate Mo-depleted wildtype mice and Ccr2-deficient mice were used to evaluate the role of all CCR2 + and CCR2 neg Mo-derived Mφs on EC apoptosis in the occluded vein.
Introduction
Branch retinal vein occlusion (BRVO) leads to extensive vascular remodeling and is an important cause of visual impairment due to vascular leakage and retinal edema. We have previously shown that experimental BRVO is associated with an acute wave of endothelial cell (EC) apoptosis of the occluded vein and the upstream capillaries, extravasation, and retinal edema. In this model, ECs subsequently proliferate and the edema resolves [1] . BRVO has also been shown to be associated with increased levels of chemokines and cytokines (including CCL2, which induces inflammatory monocytes (Mos) recruitment) in experimental BRVO [1, 2] in aqueous [3, 4] and in vitreous humor [5] [6] [7] of BRVO patients. In experimental BRVO, resident Iba1+ macrophages (rMφs) are activated and blood-derived Mφs (iMφs) are recruited [2] in the retina but their role in vascular remodeling in BRVO remains unknown. Mononuclear phagocytes (MPs) are a family of cells that include resident macrophages (rMφ), such as microglial cells (MCs) and perivascular Mφs (vasMφs) in the retina, and Mo-derived Mφs (iMφs) that are recruited to the injured tissue upon chemokine induction. Blood monocytes can be divided into two subsets [8] [9] [10] : the CCR2 + "inflammatory" monocytes, the blood-born precursors of inflammatory macrophages and inflammatory dendritic cells, and the CCR2 − "non-inflammatory" monocytes that patrol the vasculature [10, 11] but also participate in the inflammatory reaction in certain affections, such as atherosclerosis [12] . Using the laser-induced BRVO model in mice, we here confirm that Moderived Mφs are recruited to the occluded retina. Using Ccr2-deficient mice and clodronate-induced circulating Mos depletion, we identified two major subset of infiltrating MPs: 1/parenchymal Mφs (parMφs) and 2/ vasMφs that were recruited independently of CCL2/ CCR2 signaling. Mos depletion, but not CCR2 depletion, significantly exaggerated the wave of BRVO-induced EC apoptosis, suggesting that Mo-derived CCR2-negative vasMφs protect EC in BRVO against apoptosis.
Material and methods

Animals
Eight to 12-weeks-old C57BL/6JRj male mice were purchased from Janvier SA (Le Genest-Saint-Isle, France).
Ccr2
RFP/RFP (B6.129(Cg)-Ccr2 tm2.1Ifc /J) mice were purchased from Jackson Laboratory (Bar Harbor, USA). Mice were maintained at the Institut de la Vision animal facility under pathogen-free conditions. All animals were housed in a 12-h/12-h light/dark cycle with food and water available ad libitum.
Ethics statement
All manipulations were performed in accordance with the association for research in vision and ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research. In addition, all the experimental procedures were permitted by the Institutional Animal Care and Use Committee, "Comité d'éthique pour l'expérimentation animale Charles Darwin" (ID Ce5/2012/013), which also specifically approved the study reported in the present manuscript.
BRVO model
Occlusion of one branch of the retinal vein was performed by laser photocoagulation as previously described [1, 13] with slight modifications. Pupils were dilated with tropicamide (Mydriaticum, Théa, France) and phenylephrin (Neosynephrine, Europhta, France). Animals were injected with 100 μl of 1% fluorescein (FluoresceineSodique Faure 10%, Novartis Pharma, France) for dye enhancement and were immediately anesthetized by inhalation of isoflurane (Axience, France). Fundus was visualized with a slit lamp (BQ 900, Hagg-Streitt, Swiss) through a fundus laser lens (OFA 2.0 mm, Ocular Instruments Inc., USA) positioned on the mouse cornea with eye gel (Lubrithal, DechraVetxx, France). Seven to 12 laser impacts (0.5 s, 200 mW, 50 μm spot size, Laser Yag 532 Eyelite (Alcon, USA)) were performed on a superior vein, 2 to 3 disc diameter from the optic disc. The complete and the persistence of the occlusion were checked using fluorescent angiography with Micron III device (Phoenix Labs). Development of an eventual recanalization of the vein was checked during and at the end of the study by a control fundus.
Laser impacts were performed on retina away from any veins to exclude consequence of the laser alone. Mice in which retinal hemorrhage occurred or with incomplete occlusion were excluded from the study.
RT-PCR
At different times after BRVO, part of retina corresponding to the occluded area was carefully dissected in RNase-free conditions. Total RNA was isolated with Nucleospin RNAII (Macherey Nagel, France). Singlestranded cDNA was synthesized from total RNA (pretreated with DNaseI amplification grade) using oligo-dT as primer and superscript II reverse transcriptase (Life Technologies, France). Subsequent real-time polymerase chain reaction (RT-PCR) was performed using cDNA, Taqman, or SYBRgreen Gene Expression Master Mix (Life Technologies) and primers (0.5 pmol/μl) available upon request. Results were normalized by expression of S26. PCR reactions were performed in 45 cycles of 15 s at 95°C and 45 s at 60°C. Primers used during the study are listed below. 
Immunohistochemistry
Mice were killed by CO 2 inhalation, and the eyes were enucleated and fixed in 4% paraformaldehyde for 30 min at room temperature. After several washes in PBS, the cornea and lens were removed and the retina was carefully detached from RPE/choroid/sclera. The retinas were incubated overnight with primary antibodies (goat anti-collagen IV, 1:100, Serotec, USA; rabbit anti-Iba1, 1: 400, 1:500, Millipore, USA) in PBS supplemented with 0.5% Triton X-100, followed by incubation with appropriate Alexa-coupled secondary antibodies (Life Technologies). The retinas were flatmounted and viewed with a fluorescence microscope (DM5500B, Leica, France) or with a confocal microscope (FV1000, Olympus, France). All cell counting was performed in the inner retina (GCL/IPL). Vessel lengths and vascular areas were calculated with the "angiogenesis tube formation" add-in [14] available on MetaMorph 2D software (Molecular Devices, France).
MP tracing by systemic EdU injection and Mo depletion with clodronate liposomes
Repeated systemic EdU injections are able to stain monocytes in bone marrow as previously described [15] . With this procedure, 76% of CD115+ circulating monocytes showed EdU incorporation (during 4 days). Briefly, mice were treated daily by three intraperitoneal injections of EdU (50 mg/kg, Life Technologies) 1 day before BRVO and in the three following days [1] . Intraretinal proliferation was measured traced by intravitreous injections of EdU (6.7 μg/ μl, 2 μl/eye). Additionally, mice were intravenously injected with 100 μl of control liposomes (placebo control liposomes for clophosome-A) or liposomes containing clodronate (clophosome-A-anionic liposomal clodronate for macrophage depletion, FormuMax) the day of occlusion and the two following days leading to a decrease of circulation monocyte population of 84% [15] . The eyes were removed, and retinal flatmounts were labeled with Iba1 and revealed for EdU incorporation (Click-iT EdU Imaging Kit, Life Technologies) for the quantification of Iba1+ and EdU+ cells.
Terminal deoxynucleotidyl transferased UTP nick end labeling
After immunohistochemistry, retinal flatmounts were pretreated with frozen methanol for 20 min and then frozen methanol/acetic acid (2:1) for another 20 min. After washing with PBS, flatmounts were incubated overnight at 4°C with the reaction mixture as described by the manufacturer's protocol (In Situ Cell Death Detection Kit, Roche Diagnostics, USA) and then for 90 min at 37°C. After reaction was stopped by washing with PBS at RT, nuclei were counterstained with Hoechst (Sigma-Aldrich, France). The retinas were mounted, viewed, and photographed with a fluorescence microscope (DM5500B, Leica) or with a confocal microscope (FV1000, Olympus).
Statistical analysis
GraphPad Prism 5 (GraphPad Software, San Diego, USA) was used for data analysis and graphic representation. All values are reported as mean ± SEM. Statistical analysis is described in the legend of each figure. P < 0.05 was considered statistically significant.
Results
BRVO increases the number of perivascular and parenchymal mononuclear phagocytes
To better characterize the inflammatory processes in BRVO, we first quantified by RT-PCR the mRNA expression of intercellular adhesion molecule 1 (Icam-1), involved in leukocyte diapedesis, and the mononuclear phagocyte (MP) markers Cd11b and F4/80 at day 1, day 3, and day 7. The upstream retinas of the occluded veins are easily recognizable by the dilated vein and the diffused retinal extravasations. These areas were carefully dissected in RNase-free conditions (Fig. 1a) . All three transcripts were strongly and significantly induced at all investigated time points compared to non-occluded (white bar-day 0), peaking at day 3 (Fig. 1b) . Analysis at day 3 and day 7 of Iba1 (green staining) and collagen IV (ColIV, red staining) double-labeled retinal flatmounts on the occluded area (rectangle- Fig. 1a ) revealed two distinct populations of MPs in the inner retina, parenchymal and perivascular MPs. Vascular Mφs were distinguished from parenchymal Mφs by their more rounded and elongated cell bodies (Fig. 2b inset) and their physical contact with the ColIV+ retinal vein. The density of parenchymal macrophages (parMφs), located in the ganglion cell layer with no direct contact to the vasculature, increased by 46.9% at day 3 (190.1 ± 16.3 cells/mm 2 ) and + 68.3% at day 7 (217.8 ± 36.7 cells/mm 2 ) compared to non-occluded retina (129.4 ± 24.0 cells/mm 2 ; Fig. 1c-e) . Similarly, the number of elongated, ramified perivascular macrophages (vasMφs) located around the occluded vein appeared more numerous compared to non-occluded retina (Fig. 1f, g ) [16] . Cell counts of vasMφs per vein length at day 3 (24.22 ± 3.8 cells/mm) and at day 7 (25.37 ± 3.5 cells/mm) revealed a nearly twofold significant increase of vasMφs compared to non-occluded retina (12.81 ± 2.1 cells/mm) at both time points (Fig. 1h ).
Together our analysis shows that the number of both, vasMφs and parMφs, significantly increase after BRVO at 3 days and for the whole of the observation period.
The increased population of Iba-1+ cells in the inner retina after BRVO is partly due to blood-derived macrophage infiltration
To evaluate the participation of monocyte recruitment from the bloodstream versus resident Mφs and MCs in BRVO-induced MP accumulation at day 3, we injected mice three times a day for 4 days (from 24 h prior to occlusion to day 3) intraperitoneally with the traceable nucleotide EdU, which we showed marks 75% of circulating CD115 + monocytes, but not resident retinal MCs and Mφs [15] . Furthermore, we inhibited the accumulation of Mo-derived Mφs by additional daily intravenous (day 0 to day 2) of either empty control liposomes or clodronate-containing liposomes, which we showed to lower the number of circulating monocytes by at least 85% for 24 h [15] .
Micrographs of retinal areas of the mid-periphery of EdU (red staining), Iba-1 (green staining), and ColIV (white staining) triple-stained retinal flatmounts of non-occluded eyes from mice that were repeatedly injected with EdU for 4 days without liposome injection (CTL- Fig. 2a ) and of the occluded vein of 3 days post-BRVO mice (BRVO- Fig. 2b ) confirm the accumulation of Iba1 + parMφs and vasMφs upstream of the vein occlusion and surrounding retina described above. EdU + Iba1 + parMφs and vasMφs (inset Fig. 2a, b) In conclusion, our data demonstrates that parMφs and vasMφs that accumulate after BRVO are at least in part RFP/RFP mice to BRVO and quantified Mφs on Iba1 (green staining) and CollIV (red staining) double-labeled retinal flatmounts. We previously demonstrated that red fluorescent protein (RFP) expression cannot be used as a marker to determine whether a Mφ is derived from a CCR2 + monocyte as the Ccr2 promotor activity that drives the RFP expression in Ccr RFP/RFP mice quickly comes to a halt after tissue infiltration [15] . The BRVO-induced increase in a number of parMφs (Fig. 3b, c) RFP/RFP mice presenting the same level of parMφs than in non-occluded retina (CTL). Interestingly, Ccr2 deficiency had no effect on the accumulation of vasMφs (Fig. 3d, e) after BRVO.
These results suggested that contrary to the increase of parMφs, increased numbers of vasMφs are not derived from CCR2 + monocytes.
Mo-derived perivascular Mφs inhibit endothelial cell apoptosis
We have previously showed that ECs of the occluded vein undergo a wave of TUNEL+ apoptosis during the first 3 days following the obstruction followed by EC proliferation that mainly occurs thereafter [1] . TUNEL (green staining) and ColIV (red staining) double labeling of retinal flatmounts 3 days after experimental vein occlusion revealed TUNEL + ColIV + apoptotic ECs on occluded veins of control liposome-treated mice (Fig. 4a) as previously described for untreated animals [1] . However, TUNEL + ColIV + apoptotic ECs appeared more numerous in liposome clodronate-treated mice (Fig. 4b) , which lack the Mo-derived vasMφs accumulation (Fig. 2) . Interestingly, quantification of the number of TUNEL +-ColIV + apoptotic ECs upstream of the vein occlusion was significantly increased in liposome clodronatetreated mice (Fig. 4c ) but showed no difference between the wildtype and Ccr2 RFP/RFP mice (Fig. 4d ). Taken together, as others and we previously showed that intravenous liposome clodronate [17, 18] does not directly induce EC apoptosis, our data suggests that the recruitment of CCR2 neg Mo-derived vasMφs protects EC of the occluded vein from apoptosis.
Discussion
We have previously shown that experimental BRVO is associated with an acute wave of endothelial cell (EC) apoptosis of the occluded vein and the upstream capillaries followed by the subsequent proliferation of the ECs [1] . We here show that experimental BRVO is accompanied by an increased expression of Icam-1 (that plays a central role in leukocyte recruitment to an injured tissue [19] ), CD11b (an integrin that is more strongly expressed in Mo than MCs; Immgen.org), and F4/80 (EMR1, strongly expressed in macrophages during inflammation). Indeed, we demonstrate that Iba1 + Mφs accumulate after BRVO and we identified two subtypes of Mo-derived Mφs: parMφs, accumulating in the inner retinal layer upstream of the vein occlusion, and more elongated vasMφs, which are located in and around the vessel wall of the occluded vein. Our experiments demonstrated a significant accumulation as soon as post-occlusion day 3 that remained elevated through day 7. The comparatively lower CD11b and F4/80 expression by RT-PCR at day 7 compared to day 3 in the occluded retina is therefore not the result of a decrease of MP numbers but likely the result of differences in the level of expression during Mφ differentiation and activation. Using a combination of traceable nucleotide EdU injections and liposome clodronate-induced depletion of circulating, we show that the accumulation of both parMφs and vasMφs is to a considerable extent due to the recruitment and infiltration of Mo-derived Mφs. Intravenous liposome clodronate injection decreases iba1 + EdU + cell density counted 3 days after BRVO without affecting the iba1 + EdU neg cell population. We controlled that intravenous injection of liposome clodronate A B C D does not modify the density of both vasMφs and parMφs in non-occluded animals (data not shown).
We observed a significant transient increase of Ccr2 mRNA, a cytokine receptor that is strongly expressed on classical CCR2+Mo but is quickly downregulated upon recruitment to the tissue [15] and Ccl2 mRNA, its predominant cytokine. Using wildtype and CCR2 RFP/RFP mice, we demonstrate that CCR2+Mo recruitment does indeed participate in the Mφ infiltration after BRVO. Surprisingly, Ccr2 deficiency very strongly blunted the accumulation of parMφs but had no effect on vasMφs.
The observation that vasMφs can be strongly inhibited by Mo depletion, but not by Ccr2 ablation, strongly suggests that the vasMφs were recruited through a CCR2-independent mechanism. Non-classical monocytes that do not express Ccr2 and that are involved in other pathologies [11, 20] would seem a likely candidate. Indeed, a subgroup of non-classical Mo expressing high levels of the chemokine receptor CXCR4 has previously been shown to be angio-protective [21, 22] as it produces high level of VEGF [20] and specifically accumulates in the perivascular area in diseases such as autoimmune encephalomyelitis (EAE) [23] .
Similarly, our analysis of endothelial cell apoptosis 3 days post-BRVO in control liposome and liposome clodronate-treated mice, and wildtype and Ccr2
RFP/RFP mice clearly shows that the inhibition of vasMφs recruitment, but not parMφs, leads to a dramatic increase of EC apoptosis in the occluded vein.
Conclusion
Taken together, our study demonstrates for the first time an important role of blood-derived vasMφs in the vessel remodeling after BRVO. Our findings show a vasoprotective effect of blood-derived vasMφs that should be taken into consideration in the development of future therapies. 
